MFAN Partner Events: Women Thrive - May Gender Roundtable, 5/3; GHTC and Research!America - Saving Lives and Creating Impact (updated flier), 4/27
From: Mary Deering [mailto:mdeering@modernizeaid.net]
Sent: Wednesday, April 25, 2012 9:27 AM
To: Mary Deering
Subject: MFAN Partner Events: Women Thrive - May Gender Roundtable, 5/3; GHTC and Research!America - Saving Lives and Creating Impact (updated flier), 4/27
| ||||||||
The Global Health Technologies Coalition (GHTC)
and Research!America invite you to:
Saving lives and creating impact:
Why investing in global health research works
Friday, April 27, 2012
12:00–1:30 p.m.
Barbara Jordan Conference Center, Kaiser Family Foundation
1330 G Street, NW, Washington, DC
Lunch will be provided.
The US Government has long played a role in research and development (R&D) for new global health products that have transformed communities in the poorest countries in the world and saved the lives of millions. From the eradication of smallpox to the development of game-changing HIV drugs, American efforts have been central to many global health success stories throughout history. As infectious diseases continue to impact millions of people each year, the US Government has maintained this commitment and its position as the pre-eminent funder of global health R&D in the world.
In this constrained fiscal environment, new evidence on the benefits of global health R&D and the cost-effectiveness of past funding is critical. In addition, new actors are increasingly engaging in global health R&D, forming a key partnership across the public, philanthropic, and private sectors. Join us for the launch of a new report from the GHTC and Policy Cures that addresses these issues by analyzing the impact of past US Government investments, and reviewing the role of ongoing US investments in global health R&D. A high-level panel representing the US Government, private industry, and philanthropic sector will discuss key issues in global health R&D in light of the report’s findings.
Speakers:
Mr. Eric Easom, Program Leader, Neglected Diseases, Anacor Pharmaceuticals, Inc.
Dr. Javier Guzman, Director of Research, Policy Cures
Dr. Lee Hall, Chief of the Parasitology and International Programs Branch, National Institute of Allergy and Infectious Disease
Ms. Heather Ignatius, Senior Manager, Policy, Global Alliance for TB Drug Development
Moderator:
Mr. Don Joseph, CEO, BIO Ventures for Global Health
To RSVP, please contact Nick Taylor at info@ghtcoalition.org or 202.822.0033.
---
Mary Deering
Outreach Associate
MFAN|Modernizing Foreign Assistance Network
425 3rd Street SW | Suite 1200 | Washington, DC 20024
T: 202.688.1107 | C: 202-509-1040
